News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,916 Results
Type
Article (40122)
Company Profile (272)
Press Release (662522)
Multimedia
Podcasts (54)
Webinars (12)
Section
Business (205111)
Career Advice (2021)
Deals (35534)
Drug Delivery (97)
Drug Development (81249)
Employer Resources (172)
FDA (16219)
Job Trends (14920)
News (346502)
Policy (32657)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49789)
ALS (95)
Alzheimer's disease (1389)
Antibody-drug conjugate (ADC) (135)
Approvals (16217)
Artificial intelligence (265)
Autoimmune disease (23)
Automation (17)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (191)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (293)
Cancer (2328)
Cardiovascular disease (179)
Career advice (1689)
Career pathing (30)
CAR-T (158)
Cell therapy (442)
Cervical cancer (20)
Clinical research (66221)
Collaboration (866)
Company closure (2)
Compensation (569)
Complete response letters (19)
COVID-19 (2606)
CRISPR (42)
C-suite (253)
Cystic fibrosis (102)
Data (2332)
Decentralized trials (2)
Denatured (21)
Depression (44)
Diabetes (276)
Diagnostics (6400)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87192)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (113171)
Executive appointments (748)
FDA (17601)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (774)
Gene editing (111)
Generative AI (20)
Gene therapy (315)
GLP-1 (723)
Government (4444)
Grass and pollen (4)
Guidances (160)
Healthcare (18840)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (129)
Indications (29)
Infectious disease (2753)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (98)
Interviews (312)
IPO (16559)
IRA (42)
Job creations (3668)
Job search strategy (1434)
Kidney cancer (10)
Labor market (43)
Layoffs (482)
Leadership (17)
Legal (7945)
Liver cancer (76)
Lung cancer (325)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (326)
MASH (77)
Medical device (13395)
Medtech (13400)
Mergers & acquisitions (19547)
Metabolic disorders (709)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (1950)
NextGen: Class of 2025 (6548)
Non-profit (4491)
Now hiring (40)
Obesity (371)
Opinion (209)
Ovarian cancer (81)
Pain (92)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (22)
Patents (245)
Patient recruitment (116)
Peanut (46)
People (57680)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20652)
Phase II (29175)
Phase III (21709)
Pipeline (1381)
Policy (150)
Postmarket research (2564)
Preclinical (8794)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (384)
Real estate (5953)
Recruiting (65)
Regulatory (22395)
Reports (47)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (134)
Series B (88)
Service/supplier (13)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3633)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (50)
The Weekly (31)
Vaccines (702)
Venture capitalists (44)
Weight loss (238)
Women's health (36)
Worklife (16)
Date
Today (182)
Last 7 days (979)
Last 30 days (3192)
Last 365 days (32694)
2025 (11957)
2024 (35331)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38096)
Australia (6241)
California (6444)
Canada (2066)
China (540)
Colorado (276)
Connecticut (281)
Delaware (158)
Europe (81920)
Florida (957)
Georgia (215)
Idaho (58)
Illinois (550)
India (26)
Indiana (323)
Iowa (11)
Japan (172)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (923)
Massachusetts (4787)
Michigan (225)
Minnesota (404)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (64)
New Jersey (1797)
New Mexico (28)
New York (1807)
North Carolina (990)
North Dakota (8)
Northern California (2841)
Ohio (212)
Oklahoma (14)
Oregon (35)
Pennsylvania (1431)
Puerto Rico (13)
Rhode Island (33)
South America (1100)
South Carolina (26)
South Dakota (1)
Southern California (2422)
Tennessee (105)
Texas (956)
United States (24110)
Utah (188)
Virginia (152)
Washington D.C. (65)
Washington State (570)
West Virginia (3)
Wisconsin (56)
702,916 Results for "aadi bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company
March 18, 2025
·
10 min read
Press Releases
Aadi Bioscience Announces Closing of $100 Million PIPE Financing
March 5, 2025
·
5 min read
Press Releases
Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders
March 4, 2025
·
2 min read
Press Releases
Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update
March 17, 2025
·
1 min read
Press Releases
Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference
February 24, 2025
·
1 min read
Layoffs
Aadi Bioscience to Lay Off 80% of R&D Staff
Aadi Bioscience expects that pipeline adjustments and the workforce reduction will extend its cash runway into at least the second half of 2026.
August 21, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer
February 18, 2025
·
10 min read
Biotech Beach
Aadi Bioscience to Participate in the Jefferies Healthcare Conference
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with alterations in the mTOR pathway, announced today participation in the Jefferies Healthcare Conference, taking place June 5-6, 2024, in New York.
May 29, 2024
·
1 min read
Business
Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update
Aadi Bioscience, Inc. today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024.
May 1, 2024
·
2 min read
Press Releases
Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals
March 27, 2025
·
3 min read
1 of 70,292
Next
